Not applicableUnknownNCT00984685What this trial is testing"Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"Who this might be right forDepression Scranton-Temple Residency Program 100
Early research (Phase 1)Looking for participantsNCT06479811What this trial is testing[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersWho this might be right forHead and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more National Cancer Institute (NCI) 120
Not applicableStudy completedNCT02910934What this trial is testingCost-effectiveness Evaluation of Vector Control Strategies in MozambiqueWho this might be right forMalaria PATH 3,915
Not applicableStudy completedNCT01720732What this trial is testingLifeline-NET (Narrative Exposure Therapy): A Short-term Treatment for Traumatized Refugees and Asylum SeekersWho this might be right forTrauma TreatmentLifeline NETModification of Narrative Exposure Therapy University of Konstanz 32
Not applicableLooking for participantsNCT05999084What this trial is testingGeorgia Memory Net Anti-Amyloid Monoclonal Antibody RegistryWho this might be right forAlzheimer Disease Emory University 735
Not applicableUnknownNCT05268952What this trial is testingEvaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)Who this might be right forNeuroendocrine Tumors University Hospital, Antwerp 100
Very early researchActive Not RecruitingNCT05111509What this trial is testingA First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging AgentWho this might be right forNeuroendocrine Tumor Grade 2Neuroendocrine Tumor Grade 1 Yusuf Menda 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04919226What this trial is testingLutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSEWho this might be right forNeuroendocrine Tumors ITM Solucin GmbH 259
Not applicableStudy completedNCT03202420What this trial is testingStudy to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net ClinicWho this might be right forObesity Duke University 26
Not applicableStudy completedNCT02517723What this trial is testingNarrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress DisorderWho this might be right forBorderline Personality DisorderStress Disorders, Post-Traumatic Evangelisches Krankenhaus Bielefeld gGmbH 67
Not applicableStudy completedNCT01781013What this trial is testingDiabetes-Depression Care-management Adoption TrialWho this might be right forDepressionDiabetes Mellitus University of Southern California 1,485
Not applicableUnknownNCT04444401What this trial is testingRegistry on NEN Patients and COVID-19Who this might be right forNeuroendocrine TumorsCOVID-19 European Institute of Oncology 50
Not applicableActive Not RecruitingNCT01788787What this trial is testingAsk Advise Connect (AAC) Harris Heath CPRITWho this might be right forTobacco Use Cessation M.D. Anderson Cancer Center 5,212
Not applicableUnknownNCT04028232What this trial is testingInfluence of Socio-Economic Factor on Net Survival in Patients With Multiple Sclerosis in France ( ECOVIMUS).Who this might be right forC10.114.375.500 University Hospital, Caen 30,000
Not applicableStudy completedNCT01862692What this trial is testingWeb-based Parenting Intervention for Mothers of Infants At-Risk for Maltreatment (Baby-Net)Who this might be right forParenting Oregon Research Institute 222
Not applicableLooking for participantsNCT05906316What this trial is testingA Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative StudyWho this might be right forMycobacterium Avium Complex Pulmonary Disease Radboud University Medical Center 100
Post-approval studies (Phase 4)Ended earlyNCT04140409What this trial is testingSandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation OptimisationWho this might be right forNeuroendocrine TumorsCarcinoid Syndrome Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Very early researchLooking for participantsNCT05359146What this trial is testingCombined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)Who this might be right forNeuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) University Hospital, Basel, Switzerland 16
Early research (Phase 1)Looking for participantsNCT05053854What this trial is testingPARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine TumoursWho this might be right forNeuroendocrine Tumors Peter MacCallum Cancer Centre, Australia 24
Not applicableLooking for participantsNCT06760754What this trial is testingExamining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net HospitalWho this might be right forCancer M.D. Anderson Cancer Center 80